Diagnostic methods in candidemia: A systematic review of literature with meta-analysis;Métodos diagnósticos en candidemia: Una revisión sistemática de la literatura con meta-análisis

Revista Chilena de Infectologia

Volumn 28, Issue 5, 2011, Pages 423-428

  Cortés, Jorge Alberto ^a   Alejandro Concha, M ^a   Luis Eduardo Cediel, T ^a   Castillo, Juan Sebastián ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Candidemia; Fungemia; Molecular diagnostic techniques; Serology; Systematic reviews

Indexed keywords

FUNGUS ANTIBODY; FUNGUS ANTIGEN;

BLOOD; CANDIDA; CANDIDEMIA; CRITICAL ILLNESS; CROSS INFECTION; GENETICS; HUMAN; IMMUNOLOGY; INTENSIVE CARE UNIT; META ANALYSIS; MICROBIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA; CANDIDEMIA; CRITICAL ILLNESS; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 80054934608     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182011000600006     Document Type: Review

References (15)

1. Pappas P.G. Invasive candidiasis. Infect Dis Clin North Am 2006; 20: 485-506.
2. Ostrosky-Zeichner L, Pappas P G. Invasive candidiasis in the intensive care unit. Crit Care Med 2006; 34: 857-63.
3. Zaoutis T E, Prasad P A, Localio A R, Coffin S E, Bell L M, Walsh T J, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 2010; 51: e38-45.
4. Cortés J A, Reyes P, Gómez C, Buitrago G, Leal A L. Fungal bloodstream infections in tertiary care hospitals in Colombia. Rev Iberoam Micol 2011; 28: 74-8.
5. Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents 2008; 32 Suppl 2: S87-91.
6. Weinberger M, Leibovici L, Pérez S, Samra Z, Ostfeld I, Levi I, et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 2005; 61: 146-54.
7. Falagas M E, Apostolou K E, Pappas V D. Attributable mortality of candidemia: a systematic review of matched cohort and casecontrol studies. Eur J Clin Microbiol Infect Dis 2006; 25: 419-25.
8. Liberati A, Altman D G, Tetzlaff J, Mulrow C, Gotzsche P C, Ioannidis J P, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151: W65-94.
9. Ibáñez-Nolla J, Torres-Rodríguez J M, Nolla M, León M A, Méndez R, Soria G, et al. The utility of serology in diagnosing candidosis in non-neutropenic critically ill patients. Mycoses 2001; 44: 47-53.
10. Lepper P M, Wiedeck H, Geldner G, Essig A, Trautmann M. Value of Candida antigen and antibody assays for the diagnosis of invasive candidosis in surgical intensive care patients. Intensive Care Med 2001; 27: 916-20.
11. Bar W, Hecker H. Diagnosis of systemic Candida infections in patients of the intensive care unit. Significance of serum antigens and antibodies. Mycoses 2002; 45: 22-8.
12. McMullan R, Metwally L, Coyle PV, Hedderwick S, McCloskey B, O'Neill H J, et al. A prospective clinical trial of a realtime polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46: 890-6.
13. Patel G P, Simon D, Scheetz M, Crank C W, Lodise T, Patel N. The effect of time to antifungal therapy on mortality in candidemia associated septic shock. Am J Ther 2009; 16: 508-11.
14. Hassan I, Powell G, Sidhu M, Hart W M, Denning D W. Excess mortality, length of stay and cost attributable to candidaemia. J Infect 2009; 59: 360-5.
15. Schuster M G, Edwards J E, Sobel J D, Darouiche R O, Karchmer A W, Hadley S, et al. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008; 149: 83-90.